megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering

被引:123
作者
Boissel, Sandrine [1 ,2 ]
Jarjour, Jordan [3 ]
Astrakhan, Alexander [3 ]
Adey, Andrew [1 ,4 ]
Gouble, Agnes [5 ]
Duchateau, Philippe [5 ]
Shendure, Jay [4 ]
Stoddard, Barry L. [6 ]
Certo, Michael T. [2 ]
Baker, David [7 ,8 ]
Scharenberg, Andrew M. [2 ,9 ]
机构
[1] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA
[2] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA
[3] Pregenen Inc, Seattle, WA 98103 USA
[4] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA
[5] Cellectis SA, F-75013 Paris, France
[6] Fred Hutch Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA
[7] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[8] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA
[9] Univ Washington, Dept Immunol, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
DNA-BINDING SPECIFICITY; ZINC-FINGER NUCLEASES; HOMING ENDONUCLEASE; TAL EFFECTORS; BREAK REPAIR; ENZYMES;
D O I
10.1093/nar/gkt1224
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rare-cleaving endonucleases have emerged as important tools for making targeted genome modifications. While multiple platforms are now available to generate reagents for research applications, each existing platform has significant limitations in one or more of three key properties necessary for therapeutic application: efficiency of cleavage at the desired target site, specificity of cleavage (i.e. rate of cleavage at 'off-target' sites), and efficient/facile means for delivery to desired target cells. Here, we describe the development of a single-chain rare-cleaving nuclease architecture, which we designate 'megaTAL', in which the DNA binding region of a transcription activator-like (TAL) effector is used to 'address' a site-specific meganuclease adjacent to a single desired genomic target site. This architecture allows the generation of extremely active and hyper-specific compact nucleases that are compatible with all current viral and nonviral cell delivery methods.
引用
收藏
页码:2591 / 2601
页数:11
相关论文
共 44 条
[1]   Computational reprogramming of homing endonuclease specificity at multiple adjacent base pairs [J].
Ashworth, Justin ;
Taylor, Gregory K. ;
Havranek, James J. ;
Quadri, S. Arshiya ;
Stoddard, Barry L. ;
Baker, David .
NUCLEIC ACIDS RESEARCH, 2010, 38 (16) :5601-5608
[2]   Gene-editing nucleases [J].
Baker, Monya .
NATURE METHODS, 2012, 9 (01) :23-26
[3]   Engineering domain fusion chimeras from I-OnuI family LAGLIDADG homing endonucleases [J].
Baxter, Sarah ;
Lambert, Abigail R. ;
Kuhar, Ryan ;
Jarjour, Jordan ;
Kulshina, Nadia ;
Parmeggiani, Fabio ;
Danaher, Patrick ;
Gano, Jacob ;
Baker, David ;
Stoddard, Barry L. ;
Scharenberg, Andrew M. .
NUCLEIC ACIDS RESEARCH, 2012, 40 (16) :7985-8000
[4]  
Becker M., 2011, NAT METHODS, V9, P1
[5]   Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors [J].
Boch, Jens ;
Scholze, Heidi ;
Schornack, Sebastian ;
Landgraf, Angelika ;
Hahn, Simone ;
Kay, Sabine ;
Lahaye, Thomas ;
Nickstadt, Anja ;
Bonas, Ulla .
SCIENCE, 2009, 326 (5959) :1509-1512
[6]   Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting [J].
Cermak, Tomas ;
Doyle, Erin L. ;
Christian, Michelle ;
Wang, Li ;
Zhang, Yong ;
Schmidt, Clarice ;
Baller, Joshua A. ;
Somia, Nikunj V. ;
Bogdanove, Adam J. ;
Voytas, Daniel F. .
NUCLEIC ACIDS RESEARCH, 2011, 39 (12) :e82
[7]  
Certo MT, 2012, NAT METHODS, V9, P973, DOI [10.1038/NMETH.2177, 10.1038/nmeth.2177]
[8]  
Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]
[9]   Targeting DNA Double-Strand Breaks with TAL Effector Nucleases [J].
Christian, Michelle ;
Cermak, Tomas ;
Doyle, Erin L. ;
Schmidt, Clarice ;
Zhang, Feng ;
Hummel, Aaron ;
Bogdanove, Adam J. ;
Voytas, Daniel F. .
GENETICS, 2010, 186 (02) :757-U476
[10]   DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger Nucleases [J].
Cornu, Tatjana I. ;
Thibodeau-Beganny, Stacey ;
Guhl, Eva ;
Alwin, Stephen ;
Eichtinger, Magdalena ;
Joung, J. K. ;
Cathomen, Toni .
MOLECULAR THERAPY, 2008, 16 (02) :352-358